Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reunion Neuroscience Inc. - Common Shares (NQ: REUN ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Jul 31, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Reunion Neuroscience Inc. - Common Shares < Previous 1 2 Next > Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference April 03, 2024 From Reunion Neuroscience Inc. Via GlobeNewswire Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More August 14, 2023 First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published Via Benzinga Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details August 01, 2023 Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan of arrangement for MPM&rsq Via Benzinga Recap: Reunion Neuroscience Q4 Earnings June 29, 2023 Via Benzinga Reunion Neuroscience: Q4 Earnings Insights June 29, 2023 Via Benzinga What's Going On With Reunion Neuroscience Stock Today June 02, 2023 Via Benzinga Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More July 24, 2023 Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal... Via Benzinga Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application July 18, 2023 As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also... Via Benzinga Reunion Neuroscience On The Brink Of Going Private With Final Court Approval July 17, 2023 Clinical-stage psychedelics company Reunion Neuroscience (NASDAQ: REUN) is about to close on its take-private transaction with MPM BioImpact affiliates, as shareholders voted for a special resolution... Via Benzinga Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 World's Largest Psychedelics Conference Boasts 12K Attendees Via Benzinga Earnings Preview For Reunion Neuroscience February 13, 2023 Via Benzinga Reunion Neuroscience's Earnings: A Preview February 13, 2023 Via Benzinga Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3 June 29, 2023 Clinical-stage psychedelics firm Reunion Neuroscience Inc. (NASDAQ: REUN) reported fiscal results for the fourth quarter and year ended March 31 plus corporate updates. Here's a breakdown of the... Via Benzinga The 7 Most Promising Penny Stocks to Buy in June June 07, 2023 These top penny stocks for June look to have legitimate catalysts that can certainly send share prices higher. Via InvestorPlace Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More June 06, 2023 Major Investor Commits $30 Million To Psychedelics Funding Via Benzinga Traders Insights: Stocks Making Moves After Announcing News: REUN, WLDS, SPRC, QBTS June 05, 2023 Via AB Newswire Reunion Neuroscience Announces $13.1M Take-Private Transaction With Biotech Investment Firm June 01, 2023 As of May 31, clinical-stage psychedelics company Reunion Neuroscience Inc. Via Benzinga Nasdaq Surges Over 1%; Dollar General Lowers Annual Guidance June 01, 2023 U.S. stocks extended gains toward the end of trading, with Nasdaq gaining more than 1% on Thursday. The Dow traded up 0.66% to 33,125.22 while the NASDAQ rose 1.2% to 13,090.62. The S&P 500, also rose,... Via Benzinga Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 01, 2023 Gainers Reunion Neuroscience Inc. (NASDAQ: REUN) gained 95% to $1.33 after the company announced a $13.1 million take-private transaction with MPM BioImpact. Via Benzinga US Stocks Turn Higher; ISM Manufacturing PMI Drops In May June 01, 2023 U.S. stocks turned higher midway through trading, with Nasdaq gaining around 100 points on Thursday. The Dow traded up 0.27% to 32,996.06 while the NASDAQ rose 0.76% to 13,034.08. The S&P 500, also... Via Benzinga REUN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reunion Neuroscience Inc. Is Fair to Shareholders June 01, 2023 From Halper Sadeh LLC Via Business Wire Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More May 01, 2023 Oregon Pioneers Legal Psilocybin Therapy, But This Type Of License Has Yet To Be Issued Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023 May 01, 2023 Via Benzinga Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed April 25, 2023 Reunion Neuroscience (NASDAQ: REUN) no longer meets the minimum required $1.00 per-common-share for continued listing on the Nasdaq. Via Benzinga Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 19, 2023 Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court March 14, 2023 Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey. Via Benzinga Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More February 21, 2023 Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... Via Benzinga Reunion Neuroscience Touts 'Transformative' Quarter, Reaffirms Postpartum Depression Treatment February 14, 2023 Clinical-stage psychedelics biotech Reunion Neuroscience Inc. (NASDAQ: REUN) shared its unaudited financial results for the third quarter, as of Dec. 31, 2022. Cash and investments totaled $24.3... Via Benzinga Earnings Scheduled For February 14, 2023 February 14, 2023 Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.